Skip to main content
. 2003 Nov 7;6(1):R73–R77. doi: 10.1186/ar1026

Table 2.

Comparison of adverse events between placebo and active-drug arms of a trial of interferon-β-1a in patients with rheumatoid arthritisa

Adverse event Drug (n = 16) No. (%) Placebo (n = 6) No. (%)
Flu-like symptoms
 Arthralgias/myalgias 6 (38) 2 (33)
 Headache 8 (50) 1(17)
 Fatigue/weakness 2 (13) 1(17)
 Subjective fevers 3 (19) 0
 Chills 6 (38) 0
Hypertension 3 (19) 0
Oral ulcers 3 (19) 0
Pain at injection site 1 (6) 0
Insomnia 0 1(17)
Depression/anxiety 1 (6) 1(17)
Menstrual irregularities 1 (6) 1(17)
Rash 3 (19) 1(17)
Wheeze 2 (13) 0
Gastrointestinal distress
 Nausea 2 (13) 0
 Abdominal pain 2 (13) 0
 Diarrhea 0 1 (17)
Infections
 Upper respiratory infection 2 (13) 3 (50)
 Sinus infection 0 1(17)
 Infection on right arm 1 (6) 0
 Perineal fungal rash 1 (6) 0
 Varicella-zoster rash 1 (6) 0
Other (single reports only) 9 (56) * 5 (83) **

aAll the differences in occurrences were tested by Fisher's exact test (one-tailed) and were statistically not significant. *Hypoglycemia, paresthesia on left side of face, contact dermatitis, photosensitivity, flare of arthritis, cramping in toes, dysphagia, nasal lesion, blurred vision. **Hematuria, burn on arm, tachycardia, paresthesia on left leg, lymphadenopathy.